Chemotherapy Shortage: Understanding Its Impact on Cancer Patient Outcomes
In early 2023, the U.S. faced a significant shortage of two widely used chemotherapy drugs—cisplatin and carboplatin. These medications, essential for treating various types of cancer, experienced reduced availability. However, a recent analysis by researchers at the University of Pennsylvania’s Perelman School of Medicine and Penn Medicine’s Abramson Cancer Center revealed no noticeable increase in… Read More »